CANNAPHARMARX, INC.
corporate_fare Company Profile
CANNAPHARMARX, INC. (OTC:CPMD) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 2 items for CPMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-18, rated 9/10. Across its 2 most recent items scored 7 or higher, the top rating is 9/10, with 2 rated 8 or above. Recent SEC coverage for CPMD spans 10-Q.
Recent high-impact activity:
- CannaPharmaRx Q2 2026: Going Concern Doubt, $31M Working Capital Deficit, and Debt Defaults
- CannaPharmaRx Discloses Going Concern Doubt, Material Weakness, and Multiple Defaults
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$1.36M
Net Income
-$11.13M
Diluted EPS
-$0.02
Op. Cash Flow
-$789.1K
Free Cash Flow
-$794.62K
Gross Profit
-$2.08M
Operating Income
-$3.35M
Cash & Equivalents
$1.8K
Debt / Equity
0.00×
Net Margin
-8.17×
Shares Outstanding
662.5M sh
Source: 10-K · filed 2026-03-31 · accession 0001654954-26-003108
show_chartPrice Chart
Loading chart...